Skip to main content
. 2013 Aug 28;3(8):e002984. doi: 10.1136/bmjopen-2013-002984

Table 1.

Demographic and clinical characteristics

Adjunctive catheter-directed thrombolysis (n=90) Standard treatment only (n=99)
Baseline
 Age (years) 53.3 (15.7) 50.0 (15.8)
 Women 32 (35.6) 38 (38.4)
 Duration of symptoms of acute DVT (days) 6.4 (4.4) 6.8 (4.8)
 EQ-5D index 0.46 (0.39) 0.63 (0.99)
 VEINES-QOL score 50.2 (9.3) 50.1 (10.7)
 VEINES-Sym score 50.4 (9.3) 49.5 (10.7)
 No risk factor for venous thrombosis 31 (34.4) 26 (26.3)
Transient risk factors for venous thrombosis
 Surgery previous 3 months 15 (16.7) 13 (13.1)
 Trauma previous 3 months 10 (11.1) 15 (15.2)
 Short-term immobility 20 (22.2) 19 (19.2)
 Infection previous 6 weeks 6 (6.7) 9 (9.1)
 Pregnancy previous 3 months 5 (5.6) 3 (3.0)
 Hormonal replacement therapy 4 (4.4) 6 (6.1)
 Oral contraceptive pill 3 (3.3) 11 (11.1)
Permanent risk factors for venous thrombosis
 Previous venous thrombosis 9 (10.0) 9 (9.1)
 Cancer 3 (3.3) 1 (1.0)
 Obesity 9 (10.0) 11 (11.1)
 Inflammatory bowel disease 0 (0.0) 3 (3.0)
 First degree relative with venous thrombosis 9 (10.0) 13 (13.1)
 Two risk factors for venous thrombosis 26 (28.9) 18 (18.2)
 Three risk factors for venous thrombosis 10 (11.1) 14 (14.1)
 Thrombophilia
  Heterozygous F5 6025 polymorphism 23 (25.6) 22 (22.2)
  Homozygous F5 6025 polymorphism 1 (1.1) 4 (4.0)
  Other thrombophilic factor(s) 15 (16.7) 13 (13.1)

Data are mean (SD) or n (%).

DVT, deep vein thrombosis; QOL, quality of life.